TY - JOUR AU - Ben-Shlomo, A. AU - Melmed, S. PY - 2008 DA - 2008// TI - Somatostatin agonists for treatment of acromegaly JO - Mol Cell Endocrinol VL - 286 UR - https://doi.org/10.1016/j.mce.2007.11.024 DO - 10.1016/j.mce.2007.11.024 ID - Ben-Shlomo2008 ER - TY - JOUR AU - Buscail, L. AU - Esteve, J. AU - Saint-Laurent, N. AU - Bertrand, V. AU - Reisine, T. AU - O’Carroll, A. AU - Bell, G. I. AU - Schally, A. V. AU - Vaysse, N. AU - Susini, C. PY - 1995 DA - 1995// TI - Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms JO - Proc Nat Acad Sci VL - 92 UR - https://doi.org/10.1073/pnas.92.5.1580 DO - 10.1073/pnas.92.5.1580 ID - Buscail1995 ER - TY - JOUR AU - Buscail, L. AU - Vernejoul, F. AU - Faure, P. AU - Torrisani, J. AU - Susini, C. PY - 2002 DA - 2002// TI - Regulation of cell proliferation by somatostatin JO - Ann Endocrinol (Paris) VL - 63 ID - Buscail2002 ER - TY - JOUR AU - Kumar, U. AU - Grigorakis, S. I. AU - Watt, H. L. AU - Sasi, R. AU - Snell, L. AU - Watson, P. AU - Chaudhari, S. PY - 2005 DA - 2005// TI - Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1–5 and correlation with receptor protein expression and tumor pathology JO - Breast Cancer Res Treat VL - 92 UR - https://doi.org/10.1007/s10549-005-2414-0 DO - 10.1007/s10549-005-2414-0 ID - Kumar2005 ER - TY - JOUR AU - Prevost, G. AU - Hosford, D. AU - Thomas, F. PY - 1994 DA - 1994// TI - Receptors for somatostatin and somatostatin analogues in human breast tumors JO - Ann N Y Acad Sci VL - 733 UR - https://doi.org/10.1111/j.1749-6632.1994.tb17264.x DO - 10.1111/j.1749-6632.1994.tb17264.x ID - Prevost1994 ER - TY - JOUR AU - Murray, R. D. AU - Kim, K. AU - Ren, S. G. AU - Chelly, M. AU - Umehara, Y. AU - Melmed, S. PY - 2004 DA - 2004// TI - Central and peripheral actions of somatostatin on the growth hormone-IGF-I axis JO - J Clin Invest VL - 114 UR - https://doi.org/10.1172/JCI19933 DO - 10.1172/JCI19933 ID - Murray2004 ER - TY - JOUR AU - Boccardo, F. AU - Amoroso, D. PY - 2001 DA - 2001// TI - Management of breast cancer: is there a role for somatostatin and its analogs? JO - Chemotherapy VL - 47 UR - https://doi.org/10.1159/000049162 DO - 10.1159/000049162 ID - Boccardo2001 ER - TY - JOUR AU - Barrie, R. AU - Woltering, E. A. AU - Hajarizadeh, H. AU - Mueller, C. AU - Ure, T. AU - Fletcher, W. S. PY - 1993 DA - 1993// TI - Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent JO - J Surg Res VL - 55 UR - https://doi.org/10.1006/jsre.1993.1167 DO - 10.1006/jsre.1993.1167 ID - Barrie1993 ER - TY - JOUR AU - Florio, T. AU - Morini, M. AU - Villa, V. AU - Arena, S. AU - Corsaro, A. AU - Thellung, S. AU - Culler, M. D. AU - Pfeffer, U. AU - Noonan, D. M. AU - Schettini, G. PY - 2003 DA - 2003// TI - Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities JO - Endocrinology VL - 144 UR - https://doi.org/10.1210/en.2002-220949 DO - 10.1210/en.2002-220949 ID - Florio2003 ER - TY - JOUR AU - Florio, T. AU - Thellung, S. AU - Arena, S. AU - Corsaro, A. AU - Spaziante, R. AU - Gussoni, G. AU - Acuto, G. AU - Giusti, M. AU - Giordano, G. AU - Schettini, G. PY - 1999 DA - 1999// TI - Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitro JO - Eur J Endocrinol VL - 141 UR - https://doi.org/10.1530/eje.0.1410396 DO - 10.1530/eje.0.1410396 ID - Florio1999 ER - TY - JOUR AU - Liu, A. M. F. AU - Wong, Y. H. PY - 2005 DA - 2005// TI - Activation of nuclear factor ΰB by somatostatin type 2 receptor in pancreatic acinar AR42J cells involves GÎ ± 14 and multiple signaling components JO - J Biol Chem VL - 280 UR - https://doi.org/10.1074/jbc.M504264200 DO - 10.1074/jbc.M504264200 ID - Liu2005 ER - TY - JOUR AU - Reubi, J. C. AU - Waser, B. AU - Foekens, J. A. AU - Klijn, J. G. M. AU - Lamberts, S. W. J. AU - Laissue, J. PY - 1990 DA - 1990// TI - Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to egf receptors JO - Intnl J Can VL - 46 UR - https://doi.org/10.1002/ijc.2910460315 DO - 10.1002/ijc.2910460315 ID - Reubi1990 ER - TY - JOUR AU - Watt, H. L. AU - Kharmate, G. D. AU - Kumar, U. PY - 2009 DA - 2009// TI - Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells JO - Cell Signal VL - 21 UR - https://doi.org/10.1016/j.cellsig.2008.11.012 DO - 10.1016/j.cellsig.2008.11.012 ID - Watt2009 ER - TY - JOUR AU - Vikic-Topic, S. AU - Raisch, K. P. AU - Kvols, L. K. AU - Vuk-Pavlovic, S. PY - 1995 DA - 1995// TI - Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma JO - J Clin Endocrinol Metab VL - 80 ID - Vikic-Topic1995 ER - TY - JOUR AU - Pfeiffer, M. AU - Koch, T. AU - Schroder, H. AU - Laugsch, M. AU - Hollt, V. AU - Schulz, S. PY - 2002 DA - 2002// TI - Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M110373200 DO - 10.1074/jbc.M110373200 ID - Pfeiffer2002 ER - TY - JOUR AU - He, Y. AU - Yuan, X. -. m. AU - Lei, P. AU - Wu, S. AU - Xing, W. AU - Lan, X. -. l. AU - Zhu, H. -. f. AU - Huang, T. AU - Wang, G. -. b. AU - An, R. PY - 2009 DA - 2009// TI - The antiproliferative effects of somatostatin receptor subtype 2 in breast cancer cells JO - Acta Pharmacol Sin VL - 30 UR - https://doi.org/10.1038/aps.2009.59 DO - 10.1038/aps.2009.59 ID - He2009 ER - TY - JOUR AU - Bousquet, C. AU - Guillermet-Guibert, J. AU - Saint-Laurent, N. AU - Archer-Lahlou, E. AU - Lopez, F. AU - Fanjul, M. AU - Ferrand, A. AU - Fourmy, D. AU - Pichereaux, C. AU - Monsarrat, B. PY - 2006 DA - 2006// TI - Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway JO - Embo J VL - 25 UR - https://doi.org/10.1038/sj.emboj.7601279 DO - 10.1038/sj.emboj.7601279 ID - Bousquet2006 ER - TY - JOUR AU - Grant, M. AU - Kumar, U. PY - 2009 DA - 2009// TI - The role of G-proteins in the dimerisation of human somatostatin receptor types 2 and 5 JO - Regul Pept VL - 159 ID - Grant2009 ER - TY - JOUR AU - Reardon, D. B. AU - Dent, P. AU - Wood, S. L. AU - Kong, T. AU - Sturgill, T. W. PY - 1997 DA - 1997// TI - Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness JO - Mol Endocrinol VL - 11 UR - https://doi.org/10.1210/mend.11.8.9960 DO - 10.1210/mend.11.8.9960 ID - Reardon1997 ER - TY - JOUR AU - Kharmate, G. AU - Rajput, P. S. AU - Watt, H. L. AU - Somvanshi, R. K. AU - Chaudhari, N. AU - Qiu, X. AU - Kumar, U. PY - 2011 DA - 2011// TI - Role of somatostatin receptor 1 and 5 on epidermal growth factor receptor mediated signaling JO - Biochim Biophys Acta VL - 1813 UR - https://doi.org/10.1016/j.bbamcr.2011.03.006 DO - 10.1016/j.bbamcr.2011.03.006 ID - Kharmate2011 ER - TY - JOUR AU - Kharmate, G. AU - Rajput, P. S. AU - Watt, H. L. AU - Somvanshi, R. K. AU - Chaudhari, N. AU - Qiu, X. AU - Kumar, U. PY - 2011 DA - 2011// TI - Dissociation of epidermal growth factor receptor and ErbB2 heterodimers in the presence of somatostatin receptor 5 modulate signaling pathways JO - Endocrinology VL - 152 UR - https://doi.org/10.1210/en.2010-0940 DO - 10.1210/en.2010-0940 ID - Kharmate2011 ER - TY - JOUR AU - Foekens, J. A. AU - Portengen, H. AU - van Putten, W. L. J. AU - Trapman, A. AU - Reubi, J. C. AU - Alexieva-Figusch, J. AU - Klijn, J. G. M. PY - 1989 DA - 1989// TI - Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer JO - Cancer Res VL - 49 ID - Foekens1989 ER - TY - JOUR AU - Alroy, I. AU - Yarden, Y. PY - 1997 DA - 1997// TI - The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions JO - FEBS Lett VL - 410 UR - https://doi.org/10.1016/S0014-5793(97)00412-2 DO - 10.1016/S0014-5793(97)00412-2 ID - Alroy1997 ER - TY - JOUR AU - Bacus, S. S. AU - Gudkov, A. V. AU - Esteva, F. J. AU - Yarden, Y. PY - 2000 DA - 2000// TI - Expression of erbB receptors and their ligands in breast cancer: implications to biological behavior and therapeutic response JO - Breast Dis VL - 11 ID - Bacus2000 ER - TY - JOUR AU - Hatzoglou, A. AU - Ouafik, L. H. AU - Bakogeorgou, E. AU - Thermos, K. AU - Castanas, E. PY - 1995 DA - 1995// TI - Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line and decreases cell growth JO - Cancer Res VL - 55 ID - Hatzoglou1995 ER - TY - JOUR AU - Reisine, T. AU - Bell, G. I. PY - 1993 DA - 1993// TI - Molecular biology of opioid receptors JO - Trends Neurosci VL - 16 UR - https://doi.org/10.1016/0166-2236(93)90194-Q DO - 10.1016/0166-2236(93)90194-Q ID - Reisine1993 ER - TY - JOUR AU - Panagiotou, S. AU - Bakogeorgou, E. AU - Papakonstanti, E. AU - Hatzoglou, A. AU - Wallet, F. AU - Dussert, C. AU - Stournaras, C. AU - Martin, P. -. M. AU - Castanas, E. PY - 1999 DA - 1999// TI - Opioid agonists modify breast cancer cell proliferation by blocking cells to the G2/M phase of the cycle: involvement of cytoskeletal elements JO - J Cell Biochem VL - 73 UR - https://doi.org/3.0.CO;2-V DO - 3.0.CO;2-V ID - Panagiotou1999 ER - TY - JOUR AU - Persson, A. I. AU - Thorlin, T. AU - Bull, C. AU - Zarnegar, P. AU - Ekman, R. AU - Terenius, L. AU - Eriksson, P. S. PY - 2003 DA - 2003// TI - Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors JO - Eur J Neurosci VL - 17 UR - https://doi.org/10.1046/j.1460-9568.2003.02538.x DO - 10.1046/j.1460-9568.2003.02538.x ID - Persson2003 ER - TY - JOUR AU - Zagon, I. S. AU - McLaughlin, P. J. AU - Goodman, S. R. AU - Rhodes, R. E. PY - 1987 DA - 1987// TI - Opioid receptors and endogenous opioids in diverse human and animal cancers JO - J Natl Cancer Inst VL - 79 ID - Zagon1987 ER - TY - JOUR AU - Scopsi, L. AU - Balslev, E. AU - Brunner, N. AU - Poulsen, H. S. AU - Andersen, J. AU - Rank, F. AU - Larsson, L. I. PY - 1989 DA - 1989// TI - Immunoreactive opioid peptides in human breast cancer JO - Am J Pathol VL - 134 ID - Scopsi1989 ER - TY - JOUR AU - Hatzoglou, A. AU - Bakogeorgou, E. AU - Castanas, E. PY - 1996 DA - 1996// TI - The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors JO - Eur J Pharmacol VL - 296 UR - https://doi.org/10.1016/0014-2999(95)00703-2 DO - 10.1016/0014-2999(95)00703-2 ID - Hatzoglou1996 ER - TY - JOUR AU - Maneckjee, R. AU - Biswas, R. AU - Vonderhaar, B. K. PY - 1990 DA - 1990// TI - Binding of opioids to human MCF-7 breast cancer cells and their effects on growth JO - Cancer Res VL - 50 ID - Maneckjee1990 ER - TY - JOUR AU - Devi, L. A. PY - 2001 DA - 2001// TI - Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking JO - Trends Pharmacol Sci VL - 22 UR - https://doi.org/10.1016/S0165-6147(00)01799-5 DO - 10.1016/S0165-6147(00)01799-5 ID - Devi2001 ER - TY - JOUR AU - Rocheville, M. AU - Lange, D. C. AU - Kumar, U. AU - Patel, S. C. AU - Patel, R. C. AU - Patel, Y. C. PY - 2000 DA - 2000// TI - Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity JO - Science VL - 288 UR - https://doi.org/10.1126/science.288.5463.154 DO - 10.1126/science.288.5463.154 ID - Rocheville2000 ER - TY - JOUR AU - Baragli, A. AU - Alturaihi, H. AU - Watt, H. L. AU - Abdallah, A. AU - Kumar, U. PY - 2007 DA - 2007// TI - Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2: co-immunoprecipitation and fluorescence resonance energy transfer analysis JO - Cell Signal VL - 19 UR - https://doi.org/10.1016/j.cellsig.2007.07.007 DO - 10.1016/j.cellsig.2007.07.007 ID - Baragli2007 ER - TY - JOUR AU - Grant, M. AU - Collier, B. AU - Kumar, U. PY - 2004 DA - 2004// TI - Agonist-dependent dissociation of human somatostatin receptor 2 dimers: a role in receptor trafficking JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M407310200 DO - 10.1074/jbc.M407310200 ID - Grant2004 ER - TY - JOUR AU - Patel, R. C. AU - Kumar, U. AU - Lamb, D. C. AU - Eid, J. S. AU - Rocheville, M. AU - Grant, M. AU - Rani, A. AU - Hazlett, T. AU - Patel, S. C. AU - Gratton, E. PY - 2002 DA - 2002// TI - Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells JO - Proc Natl Acad Sci USA VL - 99 UR - https://doi.org/10.1073/pnas.042705099 DO - 10.1073/pnas.042705099 ID - Patel2002 ER - TY - JOUR AU - Jaquet, P. AU - Gunz, G. AU - Saveanu, A. AU - Dufour, H. AU - Taylor, J. AU - Dong, J. AU - Kim, S. AU - Moreau, J. P. AU - Enjalbert, A. AU - Culler, M. D. PY - 2005 DA - 2005// TI - Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy JO - Eur J Endocrinol VL - 153 UR - https://doi.org/10.1530/eje.1.01950 DO - 10.1530/eje.1.01950 ID - Jaquet2005 ER - TY - JOUR AU - Saveanu, A. AU - Gunz, G. AU - Guillen, S. AU - Dufour, H. AU - Culler, M. D. AU - Jaquet, P. PY - 2006 DA - 2006// TI - Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas JO - Neuroendocrinology VL - 83 UR - https://doi.org/10.1159/000095536 DO - 10.1159/000095536 ID - Saveanu2006 ER - TY - JOUR AU - Saveanu, A. AU - Lavaque, E. AU - Gunz, G. AU - Barlier, A. AU - Kim, S. AU - Taylor, J. E. AU - Culler, M. D. AU - Enjalbert, A. AU - Jaquet, P. PY - 2002 DA - 2002// TI - Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary Somatotroph adenoma cells JO - J Clin Endocrinol Metab VL - 87 UR - https://doi.org/10.1210/jc.2002-020934 DO - 10.1210/jc.2002-020934 ID - Saveanu2002 ER - TY - JOUR AU - Rivera, J. A. AU - Alturaihi, H. AU - Kumar, U. PY - 2005 DA - 2005// TI - Differential regulation of somatostatin receptors 1 and 2 mRNA and protein expression by tamoxifen and estradiol in breast cancer cells JO - J Carcinog VL - 4 UR - https://doi.org/10.1186/1477-3163-4-10 DO - 10.1186/1477-3163-4-10 ID - Rivera2005 ER - TY - JOUR AU - Xu, Y. AU - Berelowitz, M. AU - Bruno, J. F. PY - 1995 DA - 1995// TI - Dexamethasone regulates somatostatin receptor subtype messenger ribonucleic acid expression in rat pituitary GH4C1 cells JO - Endocrinology VL - 136 ID - Xu1995 ER - TY - JOUR AU - Xu, Y. AU - Song, J. AU - Berelowitz, M. AU - Bruno, J. F. PY - 1996 DA - 1996// TI - Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells JO - Endocrinology VL - 137 ID - Xu1996 ER - TY - JOUR AU - Kumar, U. PY - 2005 DA - 2005// TI - Expression of somatostatin receptor subtypes (SSTR1-5) in alzheimer’s disease brain: an immunohistochemical analysis JO - Neuroscience VL - 134 UR - https://doi.org/10.1016/j.neuroscience.2005.04.001 DO - 10.1016/j.neuroscience.2005.04.001 ID - Kumar2005 ER - TY - JOUR AU - Kumar, U. PY - 2007 DA - 2007// TI - Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus JO - J Comp Neurol VL - 504 UR - https://doi.org/10.1002/cne.21444 DO - 10.1002/cne.21444 ID - Kumar2007 ER - TY - JOUR AU - Enslen, H. AU - Brancho, D. M. AU - Davis, R. J. PY - 2000 DA - 2000// TI - Molecular determinants that mediate selective activation of p38 MAP kinase isoforms JO - Embo J VL - 19 UR - https://doi.org/10.1093/emboj/19.6.1301 DO - 10.1093/emboj/19.6.1301 ID - Enslen2000 ER - TY - JOUR AU - Zarubin, T. AU - Han, J. PY - 2005 DA - 2005// TI - Activation and signaling of the p38 MAP kinase pathway JO - Cell Res VL - 15 UR - https://doi.org/10.1038/sj.cr.7290257 DO - 10.1038/sj.cr.7290257 ID - Zarubin2005 ER - TY - JOUR AU - Berns, K. AU - Horlings, H. M. AU - Hennessy, B. T. AU - Madiredjo, M. AU - Hijmans, E. M. AU - Beelen, K. AU - Linn, S. C. AU - Gonzalez-Angulo, A. M. AU - Stemke-Hale, K. AU - Hauptmann, M. PY - 2007 DA - 2007// TI - A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer JO - Cancer Cell VL - 12 UR - https://doi.org/10.1016/j.ccr.2007.08.030 DO - 10.1016/j.ccr.2007.08.030 ID - Berns2007 ER - TY - JOUR AU - Esteva, F. J. AU - Guo, H. AU - Zhang, S. AU - Santa-Maria, C. AU - Stone, S. AU - Lanchbury, J. S. AU - Sahin, A. A. AU - Hortobagyi, G. N. AU - Yu, D. PY - 2010 DA - 2010// TI - PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer JO - Am J Pathol VL - 177 UR - https://doi.org/10.2353/ajpath.2010.090885 DO - 10.2353/ajpath.2010.090885 ID - Esteva2010 ER - TY - JOUR AU - López-Knowles, E. AU - O’Toole, S. A. AU - McNeil, C. M. AU - Millar, E. K. A. AU - Qiu, M. R. AU - Crea, P. AU - Daly, R. J. AU - Musgrove, E. A. AU - Sutherland, R. L. PY - 2009 DA - 2009// TI - PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality JO - Int J Cancer VL - 126 ID - López-Knowles2009 ER - TY - JOUR AU - Kallergi, G. AU - Agelaki, S. AU - Kalykaki, A. AU - Stournaras, C. AU - Mavroudis, D. AU - Georgoulias, V. PY - 2008 DA - 2008// TI - Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients JO - Br Cancer Res VL - 10 UR - https://doi.org/10.1186/bcr2149 DO - 10.1186/bcr2149 ID - Kallergi2008 ER - TY - JOUR AU - Gomes, I. AU - Jordan, B. A. AU - Gupta, A. AU - Rios, C. AU - Trapaidze, N. AU - Devi, L. A. PY - 2001 DA - 2001// TI - G protein coupled receptor dimerization: implications in modulating receptor function JO - J Mol Med VL - 79 UR - https://doi.org/10.1007/s001090100219 DO - 10.1007/s001090100219 ID - Gomes2001 ER - TY - JOUR AU - Nebreda, A. R. AU - Porras, A. PY - 2000 DA - 2000// TI - p38 MAP kinases: beyond the stress response JO - Trends Biochem Sci VL - 25 UR - https://doi.org/10.1016/S0968-0004(00)01595-4 DO - 10.1016/S0968-0004(00)01595-4 ID - Nebreda2000 ER - TY - JOUR AU - Campbell, R. A. AU - Bhat-Nakshatri, P. AU - Patel, N. M. AU - Constantinidou, D. AU - Ali, S. AU - Nakshatri, H. PY - 2001 DA - 2001// TI - Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M010840200 DO - 10.1074/jbc.M010840200 ID - Campbell2001 ER - TY - JOUR AU - Sabbatini, P. AU - McCormick, F. PY - 1999 DA - 1999// TI - Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis JO - J Biol Chem VL - 274 UR - https://doi.org/10.1074/jbc.274.34.24263 DO - 10.1074/jbc.274.34.24263 ID - Sabbatini1999 ER - TY - JOUR AU - Zheng, L. AU - Ren, J. Q. AU - Li, H. AU - Kong, Z. L. AU - Zhu, H. G. PY - 2004 DA - 2004// TI - Downregulation of wild-type p53 protein by HER-2/neu mediated PI3K pathway activation in human breast cancer cells: its effect on cell proliferation and implication for therapy JO - Cell Res VL - 14 UR - https://doi.org/10.1038/sj.cr.7290253 DO - 10.1038/sj.cr.7290253 ID - Zheng2004 ER - TY - JOUR AU - Gan, H. K. AU - Walker, F. AU - Burgess, A. W. AU - Rigopoulos, A. AU - Scott, A. M. AU - Johns, T. G. PY - 2007 DA - 2007// TI - The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive Untethered EGFR dimers JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M605136200 DO - 10.1074/jbc.M605136200 ID - Gan2007 ER - TY - JOUR AU - Davidson, N. E. AU - Gelmann, E. P. AU - Lippman, M. E. AU - Dickson, R. B. PY - 1987 DA - 1987// TI - Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines JO - Mol Endocrinol VL - 1 UR - https://doi.org/10.1210/mend-1-3-216 DO - 10.1210/mend-1-3-216 ID - Davidson1987 ER - TY - JOUR AU - Lichtner, R. B. AU - Menrad, A. AU - Sommer, A. AU - Klar, U. AU - Schneider, M. R. PY - 2001 DA - 2001// TI - Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors JO - Cancer Res VL - 61 ID - Lichtner2001 ER - TY - JOUR AU - Narayan, M. AU - Wilken, J. A. AU - Harris, L. N. AU - Baron, A. T. AU - Kimbler, K. D. AU - Maihle, N. J. PY - 2009 DA - 2009// TI - Trastuzumab-induced HER reprogramming in “resistant” breast carcinoma cells JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-1056 DO - 10.1158/0008-5472.CAN-08-1056 ID - Narayan2009 ER - TY - JOUR AU - Williams, G. AU - Ball, J. AU - Bloom, S. AU - Joplin, G. F. PY - 1986 DA - 1986// TI - Improvement in headache associated with prolactinoma during treatment with a somatostatin analogue: an “N of 1” study JO - N Engl J Med VL - 315 UR - https://doi.org/10.1056/NEJM198610303151816 DO - 10.1056/NEJM198610303151816 ID - Williams1986 ER -